The Alzheimer’s Disease Detect and Prevent project (ADDP) arrived on the scene at an exciting time for brain health research. In keeping with recent changes in the conceptualisation of and terminology related to Alzheimer’s disease (AD), ADDP pursued the ambitious aim of developing a digital tool to improve the detection of AD prior to the possible onset of AD dementia and combined this with programmes for reducing lifestyle risk factors related to developing AD dementia.
The project officially started on 1 November 2018 and was planned as a 2-year project (extended until 2022). It had a budget of EUR 3.5 million, distributed across 6 partners, with Danish digital therapeutics company Brain+ leading the consortium. Alzheimer Europe was a partner in this project and contributed towards the communication and the involvement activities. The latter, was being accomplished by means of a Patient and Public Involvement (PPI) approach.
This project is funded by the European Union’s Horizon 2020 research and innovation programme – Fast Track to Innovation (FTI), grant agreement 820636.
